Cite
Bosco J, Zhou Z, Gabriëls S, et al. VEGFR-1/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy. Mol Ther Methods Clin Dev. 2021;21:369-381doi: 10.1016/j.omtm.2021.03.013.
Bosco, J., Zhou, Z., Gabriëls, S., Verma, M., Liu, N., Miller, B. K., Gu, S., Lundberg, D. M., Huang, Y., Brown, E., Josiah, S., Meiyappan, M., Traylor, M. J., Chen, N., Asakura, A., De Jonge, N., Blanchetot, C., de Haard, H., Duffy, H. S., & Keefe, D. (2021). VEGFR-1/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy. Molecular therapy. Methods & clinical development, 21369-381. https://doi.org/10.1016/j.omtm.2021.03.013
Bosco, Jennifer, et al. "VEGFR-1/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy." Molecular therapy. Methods & clinical development vol. 21 (2021): 369-381. doi: https://doi.org/10.1016/j.omtm.2021.03.013
Bosco J, Zhou Z, Gabriëls S, Verma M, Liu N, Miller BK, Gu S, Lundberg DM, Huang Y, Brown E, Josiah S, Meiyappan M, Traylor MJ, Chen N, Asakura A, De Jonge N, Blanchetot C, de Haard H, Duffy HS, Keefe D. VEGFR-1/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy. Mol Ther Methods Clin Dev. 2021 Mar 23;21:369-381. doi: 10.1016/j.omtm.2021.03.013. eCollection 2021 Jun 11. PMID: 33898634; PMCID: PMC8055526.
Copy
Download .nbib